Herbal Pharmacotherapy for Hypertension and Depigmentary Skin Diseases: An Investigative Study

Hypertension and depigmentary skin diseases are among the most common chronic disorders affecting global health. Hypertension is a major cardiovascular risk factor associated with heart disease, stroke, and renal dysfunction, while depigmentary skin disorders such as vitiligo significantly affect the psychological and social well-being of individuals. Conventional therapies for both conditions are often associated with adverse effects, high costs, and variable therapeutic responses. Herbal pharmacotherapy has emerged as a promising alternative and complementary approach because of its natural origin, affordability, and multi-target pharmacological actions. This investigative study evaluates the therapeutic potential of medicinal plants in the management of hypertension and depigmentary skin diseases. Medicinal plants such as Allium sativum (garlic), Hibiscus sabdariffa, Rauwolfia serpentina, Camellia sinensis (green tea), Psoralea corylifolia, Aloe vera, Curcuma longa (turmeric), and Azadirachta indica (neem) possess bioactive phytochemicals with antihypertensive, antioxidant, anti-inflammatory, immunomodulatory, and melanogenic properties. These phytoconstituents act through multiple mechanisms including vasodilation, inhibition of angiotensin-converting enzyme, reduction of oxidative stress, modulation of inflammatory pathways, and stimulation of melanocyte activity. Recent experimental and clinical studies support the therapeutic significance of herbal medicines in reducing blood pressure and improving skin repigmentation. However, standardization, dosage regulation, and large-scale clinical validation remain essential for integrating herbal pharmacotherapy into modern healthcare systems. (frontiersin.org)